Nouvelle stratégie pour vectorisation d'ARN dans des cellules de mammifères. Utilisation d'un vecteur peptidique

Wagner, 1994, Gene inhibition using antisense oligonucleotides, Nature, 372, 333, 10.1038/372333a0 Agrawal, 1996, Antisense oligonucleotides: toward clinical trials, TIBTECH, 14, 376, 10.1016/0167-7799(96)10053-6 Harris, 1996, Strategies for targeted gene therapy, TIG, 12, 400, 10.1016/0168-9525(96)40031-2 Behr, 1989, Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA, 86, 6982 Flegner, 1987, Lipofection: A highly efficient lipld-mediated DNA-transfection procedure, 84, 7413 Felgner, 1994, Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulation, J. Biol. Chem., 269, 2550, 10.1016/S0021-9258(17)41980-6 Lewis, 1996, A serum resistant cytofectin for cellular delivery of antisense oligonucleotides and plasmid DNA, 93, 3176 Michael, 1994, Strategies to achieve targeted gene delivery via the receptor mediated endocytosis pathway, Gene Therapy, 1, 223 Bordier, 1995, Sequence specific inhibition of human immunodeficiency virus (HIV) reverse transcriptase by antisense oligonucleotides: Comparative study in cell-free assays and in HIV-infected cells, 92, 9383 Behr, 1994, Gene transfer with synthetic cationic amphiphiles: prospects for gene therapy, Bioconjugate Chem., 5, 382, 10.1021/bc00029a002 Boussif, 1995, A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine, 92, 7297 Vitiello, 1996, Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells, Gene Therapy, 3, 396 Gottschalk, 1996, A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells, Gene Therapy, 3, 448 Divita, 1995, Interface peptides as structure-based human immunodeficiency virus reverse transcriptase inhibitors, J. Biol. Chem., 270, 28642, 10.1074/jbc.270.48.28642 Mery, 1993, Disulfide linkage to polyacrylic resin for automated Fmoc peptide synthesis. Immunochemical applications of peptide resins and mercaptoamide peptides, Int. J. Peptide Protien Res., 42, 44, 10.1111/j.1399-3011.1993.tb00348.x Vidal, 1996, Solid-phase synthesis and cellular localization of a C-and/ or N-terminal labelled peptide, J. Pep. Sci., 2, 125 Müller, 1989, Co-expression of the subunits of the heterodimer of HIV-1 reverse transcriptase in Escherichia coli, J. Biol. Chem., 264, 13975, 10.1016/S0021-9258(18)71628-1 Matthews, 1987, Purification and properties of reilla reniformis luciferase, Biochemistry, 16, 85, 10.1021/bi00620a014 Sherf, 1996, Dual-Luciferase reporter assay: an advanced co-reporter technology integrating firefly and renilla luciferase assays, Promega Notes, 57, 2 Sambrook, 1989 Morris M.C., Divita G., communication personnelle Divita, 1995, Dimerization kinetics of HIV-1 and HIV-2 reverse transcriptase: A two step process, J. Mol. Biol., 245, 508, 10.1006/jmbi.1994.0042 Müller, 1991, Interaction of fluorescently labelled dideoxynucleotides with HIV-1 reverse transcriptase, Biochemistry, 30, 3709, 10.1021/bi00229a017 Girard, 1995, Delayed cyclin A and B1 degradation in non-transformed mammalian cells, J. Cell. Sci., 108, 2599, 10.1242/jcs.108.7.2599 Girard, 1991, Cyclin A is required for the onset of DNA replication in mammalian fibroblasts, Cell, 67, 1169, 10.1016/0092-8674(91)90293-8 Gallaher, 1987, Detection of a fusion sequence in the transmembrane protein of human immunodeficiency virus, Cell, 50, 327, 10.1016/0092-8674(87)90485-5 Freed, 1990, Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41, 87, 4650 Kalderon, 1984, Sequence requieremnts for nuclear location of simianvirus 40 large-T antigen, Nature, 311, 33, 10.1038/311033a0 Dingwall, 1992, The nuclear membrane, Science, 258, 942, 10.1126/science.1439805 Burstein, 1973, Fluorescence and the location of tryptophan residues in protein molecules, Photochem. Photobiol., 18, 263, 10.1111/j.1751-1097.1973.tb06422.x